An issue has been discovered in GitLab EE affecting all versions starting from 12.0 before 15.10.8, all versions starting from 15.11 before 15.11.7, all versions starting from 16.0 before 16.0.2. An attacker can clone a repository from a public project, from a disallowed IP, even after the top-level group has enabled IP restrictions on the group.
Published 2023-06-07 17:15:10
Updated 2023-06-14 02:17:29
Source GitLab Inc.
View at NVD,   CVE.org

Products affected by CVE-2023-2589

  • Gitlab » Gitlab » Enterprise Edition
    Versions from including (>=) 12.0.0 and before (<) 15.10.8
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:enterprise:*:*:*
  • Gitlab » Gitlab » Community Edition
    Versions from including (>=) 12.0.0 and before (<) 15.10.8
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:community:*:*:*
  • Gitlab » Gitlab » Enterprise Edition
    Versions from including (>=) 15.11.0 and before (<) 15.11.7
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:enterprise:*:*:*
  • Gitlab » Gitlab » Community Edition
    Versions from including (>=) 16.0.0 and before (<) 16.0.2
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:community:*:*:*
  • Gitlab » Gitlab » Community Edition
    Versions from including (>=) 15.11.0 and before (<) 15.11.7
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:community:*:*:*
  • Gitlab » Gitlab » Enterprise Edition
    Versions from including (>=) 16.0.0 and before (<) 16.0.2
    cpe:2.3:a:gitlab:gitlab:*:*:*:*:enterprise:*:*:*

Exploit prediction scoring system (EPSS) score for CVE-2023-2589

0.14%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 50 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2023-2589

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
5.9
MEDIUM CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N
2.2
3.6
GitLab Inc.
5.3
MEDIUM CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
3.9
1.4
NIST

References for CVE-2023-2589

Jump to
This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!